Leuprorelin Drugs Market Fueled by 13,000+ Gender-Affirming Surgeries and FDA’s Camcevi Approval in 2024
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, while Asia-Pacific shows the fastest growth.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5282
Format: PDF / PPT / Excel